FDA Clears New Methylphenidate Formulation for ADHD FDA Clears New Methylphenidate Formulation for ADHD

Cotempla XR-ODT is a once-daily extended-release orally disintegrating tablet formulation of methylphenidate for patients aged 6 to 17 years with ADHD.FDA Approvals

Source: Medscape Medical News Headlines - June 20, 2017 Category: Consumer Health News Tags: Psychiatry News Alert Source Type: news